Sunday , October 22 2017
Home / KEEP BUT DO NOT DISPLAY / Facts / Estimated Costs of Endocrine-Disrupting Chemical Exposure Exceed $209 Billion Annually in EU

Estimated Costs of Endocrine-Disrupting Chemical Exposure Exceed $209 Billion Annually in EU

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union $209 billion a year in actual health care expenses and lost earning potential, according to a new series of studies. Global experts in this field concluded that infertility and male reproductive dysfunctions, birth defects, obesity, diabetes, cardiovascular disease, and neurobehavioral and learning disorders were among the conditions than can be attributed in part to exposure to endocrine-disrupting chemicals (EDCs). The €157 billion estimate is conservative, and represents 1.23% of Europe’s gross domestic product (GDP). Endocrine Society’s Journal of Clinical Endocrinology and Metabolism